-
1
-
-
40349114639
-
Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: Counterpoint
-
18319050
-
J Maertens K Buve E Anaissie 2008 Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: counterpoint J Natl Compr Canc Netw 6 183 189 18319050
-
(2008)
J Natl Compr Canc Netw
, vol.6
, pp. 183-189
-
-
Maertens, J.1
Buve, K.2
Anaissie, E.3
-
2
-
-
27744541984
-
Role of new antifungal agents in prophylaxis of mycoses in high risk patients
-
10.1097/01.qco.0000185984.57135.ad 16258319
-
JA van Burik 2005 Role of new antifungal agents in prophylaxis of mycoses in high risk patients Curr Opin Infect Dis 18 479 483 10.1097/01.qco. 0000185984.57135.ad 16258319
-
(2005)
Curr Opin Infect Dis
, vol.18
, pp. 479-483
-
-
Van Burik, J.A.1
-
3
-
-
29944444166
-
Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies
-
1:CAS:528:DC%2BD28XivVGlug%3D%3D 10.1128/AAC.50.1.143-147.2006 16377679
-
GN Mattiuzzi G Alvarado FJ Giles L Ostrosky-Zeichner J Cortes S O'Brien S Verstovsek S Faderl X Zhou II Raad BN Bekele GJ Leitz I Lopez-Roman EH Estey 2006 Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies Antimicrob Agents Chemother 50 143 147 1:CAS:528:DC%2BD28XivVGlug%3D%3D 10.1128/AAC.50.1.143-147. 2006 16377679
-
(2006)
Antimicrob Agents Chemother
, vol.50
, pp. 143-147
-
-
Mattiuzzi, G.N.1
Alvarado, G.2
Giles, F.J.3
Ostrosky-Zeichner, L.4
Cortes, J.5
O'Brien, S.6
Verstovsek, S.7
Faderl, S.8
Zhou, X.9
Raad, I.I.10
Bekele, B.N.11
Leitz, G.J.12
Lopez-Roman, I.13
Estey, E.H.14
-
4
-
-
0037439347
-
Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome
-
1:CAS:528:DC%2BD3sXhtFGltLw%3D 10.1002/cncr.11094 12518369
-
GN Mattiuzzi E Estey I Raad F Giles J Cortes Y Shen D Kontoyiannis C Koller M Munsell M Beran H Kantarjian 2003 Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome Cancer 97 450 456 1:CAS:528: DC%2BD3sXhtFGltLw%3D 10.1002/cncr.11094 12518369
-
(2003)
Cancer
, vol.97
, pp. 450-456
-
-
Mattiuzzi, G.N.1
Estey, E.2
Raad, I.3
Giles, F.4
Cortes, J.5
Shen, Y.6
Kontoyiannis, D.7
Koller, C.8
Munsell, M.9
Beran, M.10
Kantarjian, H.11
-
5
-
-
9144238092
-
Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy
-
1:CAS:528:DC%2BD2cXhs1Wrtrw%3D 10.1002/cncr.11936 14745876
-
GN Mattiuzzi H Kantarjian S Faderl J Lim D Kontoyiannis D Thomas W Wierda I Raad G Garcia-Manero X Zhou A Ferrajoli N Bekele E Estey 2004 Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy Cancer 100 581 589 1:CAS:528:DC%2BD2cXhs1Wrtrw%3D 10.1002/cncr.11936 14745876
-
(2004)
Cancer
, vol.100
, pp. 581-589
-
-
Mattiuzzi, G.N.1
Kantarjian, H.2
Faderl, S.3
Lim, J.4
Kontoyiannis, D.5
Thomas, D.6
Wierda, W.7
Raad, I.8
Garcia-Manero, G.9
Zhou, X.10
Ferrajoli, A.11
Bekele, N.12
Estey, E.13
-
6
-
-
9144253891
-
Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high-risk myelodysplastic syndrome undergoing induction chemotherapy
-
1:CAS:528:DC%2BD2cXhs1Wrtr4%3D 10.1002/cncr.11930 14745874
-
GN Mattiuzzi H Kantarjian S O'Brien DP Kontoyiannis F Giles X Zhou J Lim BN Bekele S Faderl J Cortes S Pierce GJ Leitz I Raad E Estey 2004 Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high-risk myelodysplastic syndrome undergoing induction chemotherapy Cancer 100 568 573 1:CAS:528:DC%2BD2cXhs1Wrtr4%3D 10.1002/cncr.11930 14745874
-
(2004)
Cancer
, vol.100
, pp. 568-573
-
-
Mattiuzzi, G.N.1
Kantarjian, H.2
O'Brien, S.3
Kontoyiannis, D.P.4
Giles, F.5
Zhou, X.6
Lim, J.7
Bekele, B.N.8
Faderl, S.9
Cortes, J.10
Pierce, S.11
Leitz, G.J.12
Raad, I.13
Estey, E.14
-
7
-
-
0036498964
-
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis
-
1:CAS:528:DC%2BD38XitlCitbg%3D 10.1086/324620 11807679
-
DW Denning P Ribaud N Milpied D Caillot R Herbrecht E Thiel A Haas M Ruhnke H Lode 2002 Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis Clin Infect Dis 34 563 571 1:CAS:528: DC%2BD38XitlCitbg%3D 10.1086/324620 11807679
-
(2002)
Clin Infect Dis
, vol.34
, pp. 563-571
-
-
Denning, D.W.1
Ribaud, P.2
Milpied, N.3
Caillot, D.4
Herbrecht, R.5
Thiel, E.6
Haas, A.7
Ruhnke, M.8
Lode, H.9
-
8
-
-
0037043655
-
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
-
1:CAS:528:DC%2BD38XlvFKrt7o%3D 10.1056/NEJMoa020191 12167683
-
R Herbrecht DW Denning TF Patterson JE Bennett RE Greene JW Oestmann WV Kern KA Marr P Ribaud O Lortholary R Sylvester RH Rubin JR Wingard P Stark C Durand D Caillot E Thiel PH Chandrasekar MR Hodges HT Schlamm PF Troke B de Pauw 2002 Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis N Engl J Med 347 408 415 1:CAS:528:DC%2BD38XlvFKrt7o%3D 10.1056/NEJMoa020191 12167683
-
(2002)
N Engl J Med
, vol.347
, pp. 408-415
-
-
Herbrecht, R.1
Denning, D.W.2
Patterson, T.F.3
Bennett, J.E.4
Greene, R.E.5
Oestmann, J.W.6
Kern, W.V.7
Marr, K.A.8
Ribaud, P.9
Lortholary, O.10
Sylvester, R.11
Rubin, R.H.12
Wingard, J.R.13
Stark, P.14
Durand, C.15
Caillot, D.16
Thiel, E.17
Chandrasekar, P.H.18
Hodges, M.R.19
Schlamm, H.T.20
Troke, P.F.21
De Pauw, B.22
more..
-
9
-
-
0037165259
-
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever
-
1:CAS:528:DC%2BD38XmslGgsg%3D%3D 10.1056/NEJM200201243460403 11807146
-
TJ Walsh P Pappas DJ Winston HM Lazarus F Petersen J Raffalli S Yanovich P Stiff R Greenberg G Donowitz M Schuster A Reboli J Wingard C Arndt J Reinhardt S Hadley R Finberg M Laverdiere J Perfect G Garber G Fioritoni E Anaissie J Lee 2002 Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever N Engl J Med 346 225 234 1:CAS:528:DC%2BD38XmslGgsg%3D%3D 10.1056/NEJM200201243460403 11807146
-
(2002)
N Engl J Med
, vol.346
, pp. 225-234
-
-
Walsh, T.J.1
Pappas, P.2
Winston, D.J.3
Lazarus, H.M.4
Petersen, F.5
Raffalli, J.6
Yanovich, S.7
Stiff, P.8
Greenberg, R.9
Donowitz, G.10
Schuster, M.11
Reboli, A.12
Wingard, J.13
Arndt, C.14
Reinhardt, J.15
Hadley, S.16
Finberg, R.17
Laverdiere, M.18
Perfect, J.19
Garber, G.20
Fioritoni, G.21
Anaissie, E.22
Lee, J.23
more..
-
10
-
-
0036133373
-
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
-
1:STN:280:DC%2BD3MnosVOltg%3D%3D 10.1086/323335 11731939
-
S Ascioglu JH Rex B de Pauw JE Bennett J Bille F Crokaert DW Denning JP Donnelly JE Edwards Z Erjavec D Fiere O Lortholary J Maertens JF Meis TF Patterson J Ritter D Selleslag PM Shah DA Stevens TJ Walsh 2002 Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus Clin Infect Dis 34 7 14 1:STN:280:DC%2BD3MnosVOltg%3D%3D 10.1086/323335 11731939
-
(2002)
Clin Infect Dis
, vol.34
, pp. 7-14
-
-
Ascioglu, S.1
Rex, J.H.2
De Pauw, B.3
Bennett, J.E.4
Bille, J.5
Crokaert, F.6
Denning, D.W.7
Donnelly, J.P.8
Edwards, J.E.9
Erjavec, Z.10
Fiere, D.11
Lortholary, O.12
Maertens, J.13
Meis, J.F.14
Patterson, T.F.15
Ritter, J.16
Selleslag, D.17
Shah, P.M.18
Stevens, D.A.19
Walsh, T.J.20
more..
-
11
-
-
0016799829
-
Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial
-
1:STN:280:DyaE28%2FhvFeisQ%3D%3D 10.2307/2529712 1100130
-
SJ Pocock R Simon 1975 Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial Biometrics 31 103 115 1:STN:280:DyaE28%2FhvFeisQ%3D%3D 10.2307/2529712 1100130
-
(1975)
Biometrics
, vol.31
, pp. 103-115
-
-
Pocock, S.J.1
Simon, R.2
-
12
-
-
12344312699
-
-
Common Terminology Criteria for Adverse Events (CTCAE) Editor (ed)^(eds) (CTCAE). DCTD, NCI, NIH, DHHS City
-
Common Terminology Criteria for Adverse Events (CTCAE) (2003). In: Editor (ed)^(eds) Book Common Terminology Criteria for Adverse Events (CTCAE). DCTD, NCI, NIH, DHHS City. http://ctep.cancer.gov
-
(2003)
Book Common Terminology Criteria for Adverse Events
-
-
-
13
-
-
34547476613
-
Antifungal prophylaxis in chemotherapy-associated neutropenia: A retrospective, observational study
-
10.1186/1471-2334-7-70 17605773
-
A Riedel L Choe J Inciardi C Yuen T Martin BJ Guglielmo 2007 Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study BMC Infect Dis 7 70 10.1186/1471-2334-7-70 17605773
-
(2007)
BMC Infect Dis
, vol.7
, pp. 70
-
-
Riedel, A.1
Choe, L.2
Inciardi, J.3
Yuen, C.4
Martin, T.5
Guglielmo, B.J.6
-
14
-
-
35448957762
-
A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML)
-
10.1016/j.jinf.2007.07.003 17822770
-
JJ Vehreschild A Bohme D Buchheidt D Arenz U Harnischmacher CP Heussel AJ Ullmann S Mousset M Hummel P Frommolt G Wassmer I Drzisga OA Cornely 2007 A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML) J Infect 55 445 449 10.1016/j.jinf.2007.07.003 17822770
-
(2007)
J Infect
, vol.55
, pp. 445-449
-
-
Vehreschild, J.J.1
Bohme, A.2
Buchheidt, D.3
Arenz, D.4
Harnischmacher, U.5
Heussel, C.P.6
Ullmann, A.J.7
Mousset, S.8
Hummel, M.9
Frommolt, P.10
Wassmer, G.11
Drzisga, I.12
Cornely, O.A.13
-
15
-
-
46149114532
-
Results of randomized, double-blind trial of fluconazole vs. voriconazole for the prevention of invasive fungal infections in 600 allogeneic blood and marrow transplant patients
-
abstract 163
-
Wingard JR, Carter SL, Walsh TJ, Kurtzberg J, Small TN, Gersten ID, Mendizabal AM, Leather H, Confer DL, Baden LR, Maziarz RT, Stadtmauer EA, Bolanos-Meade J, Brown J, DiPersio JF, Boeckh M, Marr KA (2007) Results of randomized, double-blind trial of fluconazole vs. voriconazole for the prevention of invasive fungal infections in 600 allogeneic blood and marrow transplant patients. Blood 110: abstract 163
-
(2007)
Blood
, vol.110
-
-
Wingard, J.R.1
Carter, S.L.2
Walsh, T.J.3
Kurtzberg, J.4
Small, T.N.5
Gersten, I.D.6
Mendizabal, A.M.7
Leather, H.8
Confer, D.L.9
Baden, L.R.10
Maziarz, R.T.11
Stadtmauer, E.A.12
Bolanos-Meade, J.13
Brown, J.14
Dipersio, J.F.15
Boeckh, M.16
Marr, K.A.17
-
16
-
-
40549102818
-
Primary prophylaxis with voriconazole in patients receiving induction chemotherapy on the MRC adult acute lymphoblastic leukaemia trial (UK-ALL XII) to avoid itraconazole-enhanced vinca neurotoxicity
-
1:STN:280:DC%2BD1c7nsF2huw%3D%3D 10.1111/j.1751-553X.2007.00918.x
-
AM Whittle S Ali 2008 Primary prophylaxis with voriconazole in patients receiving induction chemotherapy on the MRC adult acute lymphoblastic leukaemia trial (UK-ALL XII) to avoid itraconazole-enhanced vinca neurotoxicity Int J Laboratory Hematology 30 173 174 1:STN:280:DC%2BD1c7nsF2huw%3D%3D 10.1111/j.1751-553X.2007.00918.x
-
(2008)
Int J Laboratory Hematology
, vol.30
, pp. 173-174
-
-
Whittle, A.M.1
Ali, S.2
-
17
-
-
2442670429
-
Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients
-
1:CAS:528:DC%2BD2cXjt1Cmu7k%3D 10.1038/sj.bmt.1704469 15034546
-
C Cordonnier S Maury C Pautas JN Bastie S Chehata S Castaigne M Kuentz S Bretagne P Ribaud 2004 Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients Bone Marrow Transplant 33 943 948 1:CAS:528:DC%2BD2cXjt1Cmu7k%3D 10.1038/sj.bmt.1704469 15034546
-
(2004)
Bone Marrow Transplant
, vol.33
, pp. 943-948
-
-
Cordonnier, C.1
Maury, S.2
Pautas, C.3
Bastie, J.N.4
Chehata, S.5
Castaigne, S.6
Kuentz, M.7
Bretagne, S.8
Ribaud, P.9
-
18
-
-
34248578429
-
Adverse effects of voriconazole: Analysis of the French Pharmacovigilance Database
-
1:CAS:528:DC%2BD2sXlvFyrsb4%3D 10.1345/aph.1H671 17456542
-
C Eiden H Peyriere M Cociglio S Djezzar S Hansel JP Blayac D Hillaire-Buys 2007 Adverse effects of voriconazole: analysis of the French Pharmacovigilance Database Ann Pharmacother 41 755 763 1:CAS:528: DC%2BD2sXlvFyrsb4%3D 10.1345/aph.1H671 17456542
-
(2007)
Ann Pharmacother
, vol.41
, pp. 755-763
-
-
Eiden, C.1
Peyriere, H.2
Cociglio, M.3
Djezzar, S.4
Hansel, S.5
Blayac, J.P.6
Hillaire-Buys, D.7
-
19
-
-
0036202635
-
Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: A dose escalation study
-
1:CAS:528:DC%2BD38Xjt1ynsr8%3D 10.1177/0091270002424005 11936564
-
HM Lazarus JL Blumer S Yanovich H Schlamm A Romero 2002 Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study J Clin Pharmacol 42 395 402 1:CAS:528: DC%2BD38Xjt1ynsr8%3D 10.1177/0091270002424005 11936564
-
(2002)
J Clin Pharmacol
, vol.42
, pp. 395-402
-
-
Lazarus, H.M.1
Blumer, J.L.2
Yanovich, S.3
Schlamm, H.4
Romero, A.5
-
20
-
-
0037110465
-
The safety of voriconazole
-
10.1086/343746 12410490
-
BA Potoski J Brown 2002 The safety of voriconazole Clin Infect Dis 35 1273 1275 10.1086/343746 12410490
-
(2002)
Clin Infect Dis
, vol.35
, pp. 1273-1275
-
-
Potoski, B.A.1
Brown, J.2
-
22
-
-
39449117139
-
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes
-
1:CAS:528:DC%2BD1cXhvVClsbY%3D 10.1086/524669 18171251
-
A Pascual T Calandra S Bolay T Buclin J Bille O Marchetti 2008 Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes Clin Infect Dis 46 201 211 1:CAS:528:DC%2BD1cXhvVClsbY%3D 10.1086/524669 18171251
-
(2008)
Clin Infect Dis
, vol.46
, pp. 201-211
-
-
Pascual, A.1
Calandra, T.2
Bolay, S.3
Buclin, T.4
Bille, J.5
Marchetti, O.6
-
23
-
-
15544389066
-
Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients
-
1:CAS:528:DC%2BD2MXhsFWlsLs%3D 10.1038/sj.bmt.1704828 15654347
-
S Trifilio R Ortiz G Pennick A Verma J Pi V Stosor T Zembower J Mehta 2005 Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients Bone Marrow Transplant 35 509 513 1:CAS:528:DC%2BD2MXhsFWlsLs%3D 10.1038/sj.bmt.1704828 15654347
-
(2005)
Bone Marrow Transplant
, vol.35
, pp. 509-513
-
-
Trifilio, S.1
Ortiz, R.2
Pennick, G.3
Verma, A.4
Pi, J.5
Stosor, V.6
Zembower, T.7
Mehta, J.8
-
24
-
-
31344478761
-
Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities
-
1:CAS:528:DC%2BD28XhsFejsb4%3D 10.1177/0091270005283837 16432276
-
K Tan N Brayshaw K Tomaszewski P Troke N Wood 2006 Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities J Clin Pharmacol 46 235 243 1:CAS:528:DC%2BD28XhsFejsb4%3D 10.1177/0091270005283837 16432276
-
(2006)
J Clin Pharmacol
, vol.46
, pp. 235-243
-
-
Tan, K.1
Brayshaw, N.2
Tomaszewski, K.3
Troke, P.4
Wood, N.5
-
26
-
-
33845942810
-
Neurological adverse events to voriconazole: Evidence for therapeutic drug monitoring
-
1:CAS:528:DC%2BD2sXhtVOisb0%3D 17183438
-
A Imhof DJ Schaer U Schanz U Schwarz 2006 Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring Swiss Med Wkly 136 739 742 1:CAS:528:DC%2BD2sXhtVOisb0%3D 17183438
-
(2006)
Swiss Med Wkly
, vol.136
, pp. 739-742
-
-
Imhof, A.1
Schaer, D.J.2
Schanz, U.3
Schwarz, U.4
-
27
-
-
46249105803
-
Hallucinations during voriconazole therapy
-
1:CAS:528:DC%2BD1cXosFekt74%3D 10.1086/588844 18491963
-
DI Zonios J Gea-Banacloche R Childs JE Bennett 2008 Hallucinations during voriconazole therapy Clin Infect Dis 47 e7 e10 1:CAS:528:DC%2BD1cXosFekt74%3D 10.1086/588844 18491963
-
(2008)
Clin Infect Dis
, vol.47
-
-
Zonios, D.I.1
Gea-Banacloche, J.2
Childs, R.3
Bennett, J.E.4
-
28
-
-
0037371527
-
Voriconazole: A new triazole antifungal agent
-
1:CAS:528:DC%2BD3sXisFals7s%3D 10.1086/367933 12594645
-
LB Johnson CA Kauffman 2003 Voriconazole: a new triazole antifungal agent Clin Infect Dis 36 630 637 1:CAS:528:DC%2BD3sXisFals7s%3D 10.1086/367933 12594645
-
(2003)
Clin Infect Dis
, vol.36
, pp. 630-637
-
-
Johnson, L.B.1
Kauffman, C.A.2
-
29
-
-
34247147624
-
Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients
-
1:CAS:528:DC%2BD2sXlt1GmtL0%3D 10.1002/cncr.22568 17351937
-
S Trifilio G Pennick J Pi J Zook M Golf K Kaniecki S Singhal S Williams J Winter M Tallman L Gordon O Frankfurt A Evens J Mehta 2007 Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients Cancer 109 1532 1535 1:CAS:528:DC%2BD2sXlt1GmtL0%3D 10.1002/cncr.22568 17351937
-
(2007)
Cancer
, vol.109
, pp. 1532-1535
-
-
Trifilio, S.1
Pennick, G.2
Pi, J.3
Zook, J.4
Golf, M.5
Kaniecki, K.6
Singhal, S.7
Williams, S.8
Winter, J.9
Tallman, M.10
Gordon, L.11
Frankfurt, O.12
Evens, A.13
Mehta, J.14
-
30
-
-
1242351713
-
Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults
-
10.1046/j.1365-2125.2003.01977.x 14748822
-
R Courtney D Wexler E Radwanski J Lim M Laughlin 2004 Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults Br J Clin Pharmacol 57 218 222 10.1046/j.1365-2125.2003.01977.x 14748822
-
(2004)
Br J Clin Pharmacol
, vol.57
, pp. 218-222
-
-
Courtney, R.1
Wexler, D.2
Radwanski, E.3
Lim, J.4
Laughlin, M.5
|